Rockwood Wealth Management, LLC Windtree Therapeutics Inc Transaction History

Rockwood Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 20, 2023	SELL	$0.14 - $6.9 $4,914 - $242,196	-35,101 Closed	0 $0
Q3 2022 Jul 20, 2023	BUY	$0.3 - $0.7 $1,500 - $3,500	5,000 Added 16.61%	35,101 $10.5 Million
Q2 2022 Jul 20, 2023	BUY	$0.38 - $1.14 $4,370 - $13,109	11,500 Added 61.82%	30,101 $12.6 Million
Q1 2022 Jul 20, 2023	BUY	$0.94 - $1.6 $4,700 - $8,000	5,000 Added 36.76%	18,601 $21.2 Million
Q4 2021 Jul 20, 2023	BUY	$1.4 - $2.31 $19,041 - $31,418	13,601 New	13,601 $21.8 Million

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $97.4M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Rockwood Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rockwood Wealth Management, LLC with notifications on news.